Literature DB >> 33436649

The prognostic roles of the prognostic nutritional index in patients with intraductal papillary mucinous neoplasm.

Yukiyasu Okamura1, Teiichi Sugiura2, Takaaki Ito2, Yusuke Yamamoto2, Ryo Ashida2, Katsuhisa Ohgi2, Keiko Sasaki3, Hiroto Narimatsu4, Katsuhiko Uesaka2.   

Abstract

The preoperative accurate diagnosis is difficult in the patients with intraductal papillary mucinous neoplasm (IPMN). The aim of the present study was to elucidate the roles of systemic inflammation responses and nutritional status indexes in IPMN. High-grade dysplasia was classified as a malignant neoplasm in the study. We retrospectively reviewed 155 patients who underwent pancreatectomy. The correlation between the clinical factors and several indexes of a systemic inflammation response and nutritional status was analyzed. Among the biomarkers, prognostic nutritional index (PNI) value of malignant IPMN patients was significantly lower than that of benign IPMN patients (P = 0.023), whereas PNI was not significant predictor for malignant IPMN. The multivariate analysis showed that a PNI < 43.5 (odds ratio [OR] 16.1, 95% CI 1.88-138.5, P = 0.011) and a carbohydrate antigen (CA) 19-9 level > 22.5 U/mL (OR 6.64, 95% CI 1.73-25.6, P = 0.006) were significant independent predictors of the presence of lymph node metastasis (LNM). Our scoring system developed based on these two factors. Patients with a score of 0 had no LNM and zero disease-related death. The present study suggested the roles of PNI on the IPMN patients who undergo curative pancreatectomy.

Entities:  

Year:  2021        PMID: 33436649      PMCID: PMC7803756          DOI: 10.1038/s41598-020-79583-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  27 in total

1.  American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts.

Authors:  Santhi Swaroop Vege; Barry Ziring; Rajeev Jain; Paul Moayyedi
Journal:  Gastroenterology       Date:  2015-04       Impact factor: 22.682

2.  Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.

Authors:  Motokazu Sugimoto; Irmina A Elliott; Andrew H Nguyen; Stephen Kim; V Raman Muthusamy; Rabindra Watson; O Joe Hines; David W Dawson; Howard A Reber; Timothy R Donahue
Journal:  JAMA Surg       Date:  2017-01-18       Impact factor: 14.766

3.  Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.

Authors:  Stefano Partelli; Carlos Fernandez-Del Castillo; Claudio Bassi; William Mantovani; Sarah P Thayer; Stefano Crippa; Cristina R Ferrone; Massimo Falconi; Paolo Pederzoli; Andrew L Warshaw; Roberto Salvia
Journal:  Ann Surg       Date:  2010-03       Impact factor: 12.969

4.  Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis.

Authors:  Jordan M Winter; Wei Jiang; Olca Basturk; Mari Mino-Kenudson; Zhi Ven Fong; Wei Phin Tan; Harish Lavu; Charles M Vollmer; Emma E Furth; Dana Haviland; David S Klimstra; William R Jarnagin; Keith D Lillemoe; Charles J Yeo; Carlos Fernandez-Del Castillo; Peter J Allen
Journal:  Ann Surg       Date:  2016-04       Impact factor: 12.969

5.  Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma.

Authors:  Adam C Yopp; Nora Katabi; Maria Janakos; David S Klimstra; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; Murray F Brennan; William R Jarnagin; Peter J Allen
Journal:  Ann Surg       Date:  2011-05       Impact factor: 12.969

6.  Nutritional predictors of postoperative outcome in pancreatic cancer.

Authors:  M Kanda; T Fujii; Y Kodera; S Nagai; S Takeda; A Nakao
Journal:  Br J Surg       Date:  2011-02       Impact factor: 6.939

7.  Update on pancreatic intraepithelial neoplasia.

Authors:  Ralph H Hruban; Anirban Maitra; Michael Goggins
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

8.  Neutrophil-to-lymphocyte ratio and mural nodule height as predictive factors for malignant intraductal papillary mucinous neoplasms.

Authors:  Yusuke Watanabe; Yusuke Niina; Kazuyoshi Nishihara; Takafumi Okayama; Sadafumi Tamiya; Toru Nakano
Journal:  Acta Chir Belg       Date:  2018-01-15       Impact factor: 1.090

9.  Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors:  Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

10.  Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.

Authors:  M Stotz; A Gerger; F Eisner; J Szkandera; H Loibner; A L Ress; P Kornprat; W AlZoughbi; W A Zoughbi; F S Seggewies; C Lackner; T Stojakovic; H Samonigg; G Hoefler; M Pichler
Journal:  Br J Cancer       Date:  2013-06-25       Impact factor: 9.075

View more
  1 in total

1.  Prognostic Significance of PNI in Patients With Pancreatic Head Cancer Undergoing Laparoscopic Pancreaticoduodenectomy.

Authors:  Peng Jiang; Xiaocheng Li; Shupeng Wang; Yahui Liu
Journal:  Front Surg       Date:  2022-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.